Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03530397
Title A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Pembrolizumab + Pemetrexed Disodium

Durvalumab

Carboplatin + MEDI5752 + Pemetrexed Disodium

MEDI5752

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP


No variant requirements are available.